PathwayHeart Valve Critical Pathway and Heart Valve Clinic: Novel Benchmarks for Modern Management of Valvular Heart DiseasePavone, Natalia MD, PhD*; Burzotta, Francesco MD, PhD*,†; Bruno, Piergiorgio MD, PhD*,†; Spalletta, Claudio MD*; Farina, Piero MD*; Cammertoni, Federico MD*; Nesta, Marialisa MD, PhD*; Chiariello, Giovanni A. MD*; Grandinetti, Maria MD*; De Belvis, Antonio G. MD*,†; Marzetti, Emanuele MD, PhD*,†; Angeletti, Carmen MD*; Pasquini, Annalisa MD, PhD*; Mazza, Andrea MD*; Iafrancesco, Mauro MD*; Trani, Carlo MD*,†; Lombardo, Antonella MD*,†; Massetti, Massimo MD, PhD*,†Author Information From the *Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italia †Università Cattolica del Sacro Cuore, Roma, Italia. Received for publication February 1, 2021; accepted March 28, 2021. Reprints: Natalia Pavone, MD, PhD, Dipartimento di Scienze Cardiovascolari e Toraciche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, L.go A. Gemelli 1, 00168 Rome, Italy. E-mail: [email protected]. Critical Pathways in Cardiology: September 2021 - Volume 20 - Issue 3 - p 126-133 doi: 10.1097/HPC.0000000000000260 Buy Metrics Abstract The growing burden of valvular heart disease in Western countries represents a challenge for the daily clinical practice, especially in the light of the ever-increasing number of therapeutic options. The Euro Heart Survey showed that, among elderly subjects with severe, symptomatic valve dysfunction, surgery is denied for 33% of patients with aortic stenosis and for 50% of patients with mitral regurgitation. Current management (from diagnosis to follow-up) is often fragmented in multiple—sometimes unnecessary—steps. Such a “patchy” approach may translate into a suboptimal management, especially in the geriatric population. New healthcare models exist that can coordinate care, reduce fragmentation, limit costs and, ultimately, improve outcomes: the clinical pathways. Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.